Angela Kim, MD
Retina Specialist · Bellaire, TXNPI 1437654159
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (58.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Alcon at 35.1% of the total. Reporting peaked in 2022 at $4,727 and has fallen 84.4% since, to $737 in 2025.
Across 74 payments — averaging $100.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$3K
- Bausch & Lomb Americas Inc.$2K
- Regeneron Healthcare Solutions, Inc.$420
- Alimera Sciences, Inc.$419
- Sight Sciences, Inc.$327
- Genentech USA, Inc.$314
- plus $1K from 11 others
What the payments were for
- Travel & lodging$2,97640%
- Food & beverage$4,36559%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 14 | $2,609 |
| Bausch & Lomb Americas Inc. | 19 | $2,223 |
| Regeneron Healthcare Solutions, Inc. | 9 | $420 |
| Alimera Sciences, Inc. | 5 | $419 |
| Sight Sciences, Inc. | 3 | $327 |
| Genentech USA, Inc. | 7 | $314 |
| Astellas Pharma US Inc | 4 | $185 |
| AbbVie(2 entities) | 2 | $179 |
| Apellis Pharmaceuticals, Inc. | 2 | $152 |
| Genentech, Inc. | 1 | $127 |
| Ivantis, Inc | 1 | $97 |
| Regeneron | 1 | $97 |
| Eyepoint US, Inc. | 2 | $95 |
| Optos, Inc. | 1 | $87 |
| Revance Therapeutics, Inc. | 1 | $44 |
| ANI Pharmaceuticals, Inc. | 1 | $41 |
| Biogen | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS$1,698
- OPHTHALMIC INSTRUMENTS$1,596
- VABYSMO$253
- OMNI(R) SURGICAL SYSTEM (US)$252
- EYLEA HD$229
- Iluvien$141
- Clareon$138
- AcrySof IQ PanOptix$138
- Izervay$110
- AcrySof IQ VIVITY IOL$107
- TOTAL30$107
- Precision7$107
- Precision 1$107
- DAILIES TOTAL1$107
- Constellation$106
- ARGOS$100
How this compares
$7,441 in reported general payments places this provider in the 70th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Bellaire
- Emmanuel ChangBellaire$254K
- Ting Fang SuarezBellaire$156K
- Paul StewartBellaire$4K
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Judy KimDallas$256K
- Hemang PandyaPlano$153K
- Margaret RunnerSouthlake$71K
- Moises ChicaSan Antonio$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.